The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients.,American Journal of Clinical Oncology

当前位置： X-MOL 学术 › Am. J. Clin. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients.
American Journal of Clinical Oncology ( IF 1.6 ) Pub Date : 2021-06-07 , DOI: 10.1097/coc.0000000000000839
Gregory S Merrick _{1,

2} , Robert Galbreath ₁ , Ryan Fiano ₁ , Whitney Scholl ₁ , Abbey Bennett ₁ , Wayne M Butler ₁ , Brian Kurko ₁ , Edward Adamovich ₃

Affiliation

The objective of this study was to evaluate the impact of body mass index (BMI) on overall survival, freedom from distant metastases, rates of therapeutic intervention (TI), and quality of life (QOL) in active surveillance (AS) prostate cancer patients.

中文翻译：